Evidence map›Paper›PMID 36107376›Full record

ArticleMolecular biology reports2022

Impact of NMDA receptor activation on DNA damage in PC12 neuron-like cell cultures in the presence of β-amyloid peptides.

Benita Wiatrak, Przemysław Mieszała, Kazimierz Gąsiorowski

Open access · hybridAbstract read
In one paragraph

Article in Molecular biology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Systematic characterization of a non-transgenic AβBiology of sex differences · 2023
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Benita WiatrakDepartment of Basic Medical Sciences, Wroclaw Medical University, Borowska 211, 50-556, Wroclaw, Poland. benita.wiatrak@umw.edu.pl.ORCID http://orcid.org/0000-0002-1404-2274
Przemysław MieszałaDepartment of Basic Medical Sciences, Wroclaw Medical University, Borowska 211, 50-556, Wroclaw, Poland.
Kazimierz GąsiorowskiDepartment of Basic Medical Sciences, Wroclaw Medical University, Borowska 211, 50-556, Wroclaw, Poland.
Wroclaw Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to investigate the effect of low nanomolar concentrations of Aβ1-40 and Aβ25-35 on DNA double-strand breaks following NMDA activation of cells. MATERIALS AND

methodsAfter incubating the differentiated PC12 cells with Aβ

resultsIt was found that amyloid peptides in nanomolar concentrations reduce double-stranded DNA breaks after NMDA neuron activation. A slight antioxidant effect was also demonstrated when measured 120 min after NMDA cell activation.

conclusionThe NMDA stimulation of PC12 cells led to a rapid increase in the number of double-stranded DNA breaks in the cells and is assumed to be the initial step in IEG activation and LTP induction. The effect of Aβ on the reduction of double-strand breaks after NMDA cell stimulation indicates that at concentrations similar to physiological amyloid peptides, it may reduce the mobilization of the neuronal response to stimuli, leading to inhibition of LTP induction and decreasing synaptic plasticity in the early stages of Alzheimer's disease.

Indexed as

N-MethylaspartateReceptors, N-Methyl-D-AspartateAmyloidAmyloid beta-PeptidesAnimalsCell Culture TechniquesDNA DamageHippocampusNeuronsPC12 CellsPeptide FragmentsRatsAmyloidAmyloid beta-PeptidesN-MethylaspartatePeptide FragmentsReceptors, N-Methyl-D-AspartateAlzheimer’s diseaseLong-term potentiationNMDA receptorβ-amyloid

Identifiers

PMID36107376
PMCPMC9618537
OpenAlexW4295908427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.